Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

Akouos Appoints Dr. Kathy Reape as Chief Development Officer
Read Me

Escient Pharmaceuticals Names Svetlana Makhni As Chief Financial Officer
Read Me

Entrada Therapeutics Appoints Biotech Industry Leader Mary Thistle to Its Board of Directors
Read Me

Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annual Meeting
Read Me

Akouos to Present Nonclinical Data from AK-OTOF and AK-antiVEGF Programs at the American Society of Gene and Cell Therapy 24th Annual Meeting

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 18,000 patients enrolled across 750 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA

San Francisco

501 Second Street
Suite 350
San Francisco, CA 94107

Tel: 415-993-8570
Boston

200 Clarendon Street
45th Floor
Boston, MA 02116

Tel: 857-305-1825

© 2021 5AM Venture Management LLC